Exchange: NASDAQ·Updated 07:30 PM EDT
VRAX logo

VRAX Virax Biolabs Group Ltd

$2.40
$0.20
(9.09%)
Today
Closed $2.40
$0.00
(0.00%)
After Hours
Mkt Cap$2.96M
Vol2.89M

About VRAX

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
74

Bullish Sentiment

How do you feel about VRAX?

Community Summary

Discussion is dominated by VRAXs sharp, volatile swings and repeated pump-and-dump concerns, with frustrated bearish holders citing dilution and selling pressure while speculative bulls point to the Fosun deal, the investor webinar, and possible short squeezes as reasons for optimism.

Last updated: 8h agoAI generated, may contain errors

ciccarj
$VRAX sold my 30k shares above 3. I know this stock is heavily shorted debating if I should buy back?
YouVSYou
Reclaim 2.40 and hold the retest / watch 2.63–2.65 then 2.90–3.01 / lose 2.26 and watch 2.14 then 2.02 $VRAX
TraderBuckNKY
$VRAX ...Just out:...Prospectus Rule 434B3... of up to 1,682,360 ordinary shares, par value $0.025 per share (the “Ordinary Shares”), issuable upon exercise of (i) warrants to purchase up to 1,644,000 Ordinary Shares, consisting of Series A Ordinary Share Preferred Investment Options to purchase up to an aggregate of 548,000 Ordinary Shares (the “Series A Preferred Investment Options”) and Series B Ordinary Share Preferred Investment Options to purchase up to an aggregate of 1,096,000 Ordinary Shares (the “Series B Preferred Investment Options,” and together with the Series A Preferred Investment Options, the “New Warrants”), which were issued by us pursuant to an inducement letter agreement dated July 9, 2026 .The exercise price of the New Warrants is $ 6.00 per share. See “Use of Proceeds”. The exercise price of the Placement Agent Warrants is $7.50 per share.

Advertisement|Remove ads.